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Abstract
Background: A recent study using a rat model found significant differences at the time of diabetes onset in the
bacterial communities responsible for type 1 diabetes modulation. We hypothesized that type 1 diabetes in
humans could also be linked to a specific gut microbiota. Our aim was to quantify and evaluate the difference in
the composition of gut microbiota between children with type 1 diabetes and healthy children and to determine
the possible relationship of the gut microbiota of children with type 1 diabetes with the glycemic level.
Methods: A case-control study was carried out with 16 children with type 1 diabetes and 16 healthy children. The
fecal bacteria composition was investigated by polymerase chain reaction-denaturing gradient gel electrophoresis
and real-time quantitative polymerase chain reaction.
Results: The mean similarity index was 47.39% for the healthy children and 37.56% for the children with diabetes,
whereas the intergroup similarity index was 26.69%. In the children with diabetes, the bacterial number of
Actinobacteria and Firmicutes, and the Firmicutes to Bacteroidetes ratio were all significantly decreased, with the
quantity of Bacteroidetes significantly increased with respect to healthy children. At the genus level, we found a
significant increase in the number of Clostridium, Bacteroides and Veillonella and a significant decrease in the
number of Lactobacillus, Bifidobacterium, Blautia coccoides/Eubacterium rectale group and Prevotella in the children
with diabetes. We also found that the number of Bifidobacterium and Lactobacillus, and the Firmicutes to
Bacteroidetes ratio correlated negatively and significantly with the plasma glucose level while the quantity of
Clostridium correlated positively and significantly with the plasma glucose level in the diabetes group.
Conclusions: This is the first study showing that type 1 diabetes is associated with compositional changes in gut
microbiota. The significant differences in the number of Bifidobacterium, Lactobacillus and Clostridium and in the
Firmicutes to Bacteroidetes ratio observed between the two groups could be related to the glycemic level in the
group with diabetes. Moreover, the quantity of bacteria essential to maintain gut integrity was significantly lower
in the children with diabetes than the healthy children. These findings could be useful for developing strategies to
control the development of type 1 diabetes by modifying the gut microbiota.
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Background
Type 1 diabetes is a worldwide problem, mainly in
children, and it is associated with a significant burden,
mostly related to the development of vascular complica-
tions [1]. Type 1 diabetes is the result of a complex interac-
tion between different degrees of genetic susceptibility and
environmental factors [2-4]. The intestinal microbiota is
one of these environmental factors currently under study,
partly as a result of observations in both non-obese
diabetic (NOD) mice and BioBreeding diabetes-prone rats,
where the use of antibiotics was shown to prevent the
onset of diabetes [5,6]. Moreover, a recent study using
NOD mice suggested that the development of type 1 dia-
betes can be prevented through modulation of the intest-
inal microbiota [7]. Newly, Vaarala et al. suggested that the
interaction between the intestinal environment, the barrier
function and the immune system are crucial in the onset
of type 1 diabetes [4]. Using a rat model, Roesch et al.
found significant differences at the time of diabetes onset
in the bacterial communities responsible for type 1 dia-
betes modulation [8]. Moreover, other studies have shown
that beneficial bacteria, such as probiotic bacteria, have a
protective effect in rodent models by delaying or prevent-
ing the onset of type 1 diabetes [9,10]. With respect to
mechanisms of action, Wen et al. found that the gut
microbiome of NOD mice lacking an adaptor for multiple
innate immune receptors responsible for recognizing
microbial stimuli correlates with the disease onset, reveal-
ing a relationship between gut microbiota and the immune
system [11]. Recent studies have demonstrated that com-
mensal bacteria are crucial for maturation and function of
the mucosal immune system. The balance between two
major effector T cell populations in the intestine, IL-17+ T
helper 17 cells and Foxp3+ regulatory T cells, requires sig-
nals from commensal bacteria and is dependent on the
composition of the intestinal microbiota [12-14]. In addi-
tion, increased gut permeability has been observed in
patients with type 1 diabetes as well as in NOD mouse and
BioBreeding rat models [15-18]. It has been suggested that
this increased gut permeability (commonly called leaky
gut) may affect the absorption of antigens that can attack
and damage pancreatic beta cells [19]. Because gut
microbes can affect intestinal permeability, the gut ecology
may play a role in the development of type 1 diabetes [20].
Only a few studies have evaluated the ecology of intest-
inal microbiota in autoimmune children who were not yet
diabetic [21,22]. These studies used a very low number of
participants (four patients and four controls) and neither
of them have controlled for such an important factor as
the mode of delivery (natural birth or Cesarean) or the
type and time of infant feeding (formula-fed or breast-fed),
both of which determine the gut microbial composition
during infancy [23,24].
The aim of the present study, therefore, was to charac-
terize the composition of fecal microbiota in children with
type 1 diabetes as compared with children without dia-
betes (controlling for such factors as mode of delivery and
breastfeeding time) using PCR-denaturing gradient gel
electrophoresis (DGGE) and real-time quantitative PCR
(qPCR) analysis. This was to determine whether there
were significant differences in the gut microbiota composi-
tion between these groups and, if so, to quantify the differ-
ences and determine the possible relation of the gut
microbiota of children with type 1 diabetes with their gly-
cemic level.
Methods
Study participants and design
The case-control study included 16 Caucasian children
with type 1 diabetes, aged 7.16 ±0.72 years, and 16
healthy Caucasian children, aged 7.48 ±0.87 years. Type
1 diabetes was diagnosed following the criteria of the
American Diabetes Association [25,26] and the appear-
ance of at least two persistent, confirmed anti-islet auto-
antibodies (insulin autoantibodies, glutamic acid
decarboxylase autoantibodies or tyrosine phosphatase
autoantibodies). The patients with diabetes were treated
and monitored according to a standard medical proto-
col. Patients were excluded if they had any other acute
or chronic inflammatory diseases or infectious diseases
at study entry. The study participants received no
antibiotic treatment, probiotics, prebiotics or any other
medical treatment influencing intestinal microbiota
during the 3 months before the start of the study. The
selected healthy children were all type 1 diabetes auto-
antibody negative and they were matched to the chil-
dren with diabetes for age, gender, race, mode of
delivery and duration of breastfeeding. The parents of
the patients and controls completed a structured inter-
view to obtain the following data: health status, lifestyle
aspects (such as living environment and physical activ-
ity) and dietary habit. The dietary intake patterns in
patients and controls were determined from a food
frequency questionnaire that allowed us to assess the
consumption of groups of foods. The written guardian
or parental consents of the children were obtained. The
sampling and experimental processes were performed
with the approval of the local Ethics Committee of
Ciudad de Jaen hospital. Stool samples were collected by
parents at home and delivered to the storage area for
frozen storage at -80ºC within one hour [27].
Anthropometric measurements
Body weight and height were measured according to
standardized procedures [28].
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Laboratory measurements
Fasting venous blood samples were collected. The serum
was separated in aliquots and immediately frozen at -80ºC.
Serum biochemical parameters were measured in dupli-
cate. Serum glucose, cholesterol and triglycerides were
measured using a standard enzymatic method (Randox
Laboratories Ltd., Antrim, UK). The quantitative detection
of autoantibodies to islet cell antigens was done using the
Elisa RSR GADAb Kit, Elisa RSR IA-2Ab Kit and RIA RSR
IAA Kit (RSR Limited, Cardiff, UK).
DNA extraction from fecal samples
Fecal samples were immediately kept after collection at
-80°C and stored until analyzed. DNA extraction from
200 mg of stools was done using the QIAamp DNA Stool
Mini Kit (Qiagen, Hilden, Germany) following the manu-
facturer’s instructions. The DNA concentration was deter-
mined by absorbance at 260 nm (A260), and the purity
was estimated by determining the A260 to A280 ratio with
a Nanodrop spectrophotometer (Nanodrop Technologies,
Wilmington, DE, USA).
Analysis of fecal microbiota by PCR-DGGE
Fecal samples from each participant were examined by
determining PCR-DGGE profiles as recently published by
us [29]. The V2 to V3 regions of the 16S rRNA genes
(positions 339 to 539 in the Escherichia coli gene) of
bacteria in the fecal samples were amplified by primers
HDA1-GC (5′-CGC CCG CCG CGC GCG GCG GGC
GGG GCG GGG GCA CGG GGG GCC TAC GGG
AGG CAG CAG T-3′; (the GC clamp is in boldface)) and
HDA2 (5′-GTA TTA CCG CGG CTG CTG GCA C-3′)
generating a 200 bp product. Aliquots (2 μL) of DNA
were amplified by real-time PCR (20 μL final volume) in a
7500 Fast Real-Time PCR Systems instrument using Fast
SYBR Green Master Mix and 200 nM of each of the uni-
versal primers HDA1-GC or HDA2 with the following
amplification program: initial denaturation at 95°C for 20
s; amplification using 45 cycles including denaturation at
95°C for 3 s; annealing at 55°C for 30 s; and extension at
72°C for 1 min. Negative controls without a DNA template
were included in each analysis.
After real-time PCR, 15 μL of products were mixed with
6 μL of loading dye before loading. Electrophoresis was
performed with a DCode Universal Mutation Detection
System instrument (Bio-Rad Laboratories, S.A, Madrid,
Spain). Six percent polyacrylamide gels were prepared and
electrophoresed with 1× TAE buffer prepared from 50×
TAE buffer (2 M Tris base, 1 M glacial acetic acid, 50 mM
ethylenediaminetetraacetic acid (EDTA)). The denaturing
gradient was formed by using two 6% acrylamide (acryla-
mide to bisacrylamide ratio 37.5:1) stock solutions
(Bio-Rad). The gels contained a 20% to 80% gradient of
urea and formamide that increases in the direction of
electrophoresis. Electrophoretic runs were in a TAE buffer
(40 mmol/L Tris, 20 mmol/L acetic acid, and 1 mmol/L
EDTA, pH 7.4) at 130 V and 60°C for 4.5 h. Electrophor-
esis was stopped when a xylene cyanol dye marker reached
the bottom of a gel. Gels were stained with ethidium
bromide (0.5 mg/L) for 5 min, rinsed with deionized
water, viewed by UV transillumination and photographed
with Gelcapture image acquisition software (DNR Bio-
Imaging Systems Ltd, Mahale HaHamisha, Jerusalen,
Israel). All the samples were analyzed on the same DGGE
run to avoid the possible influence of variations in electro-
phoretic conditions between different runs. No band was
observed in the negative controls. Similarities between
banding patterns in the DGGE profile were calculated
based on the presence and absence of bands and expressed
as a similarity coefficient. Gels were analyzed using BioNu-
merics software (Applied Maths, Sint-Martens-Latem, Bel-
gium). Normalized banding patterns were used for cluster
analysis. The Dice similarity coefficient was used to calcu-
late pairwise comparisons of the DGGE fingerprint profiles
obtained. A similarity coefficient value of 100% indicates
that DGGE profiles are identical while completely different
profiles result in a similarity coefficient value of 0%. The
unweighted pair group method with arithmetic mean
algorithm was used for construction of dendrograms.
Sequencing of selected bands from DGGE gels
Bands were excised from DGGE gels with a sterile razor,
placed in 40 μL sterile water and incubated at 4°C for diffu-
sion of DNA into the water. DNA were used in a second
PCR with HDA1/2 primers without a GC-clamp (initial
denaturation at 95°C for 20 s, followed by 45 cycles includ-
ing denaturation at 95°C for 3 s, annealing at 55°C for 15 s
and extension at 72°C for 10 s). Subsequently, the PCR pro-
ducts were directly cloned into pCR 4-TOPO (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
instructions. Plasmid DNA was isolated from the cells
using the Qiagen Mini Spin Prep Kit (Qiagen), and
subjected to PCR (HDA1/2-GC) as earlier described. PCR
products were diluted until 20 ng/μL, purified with
ExoSAP-IT (USB Corporation, Cleveland, OH, USA) and
sequenced in an ABI 3130 (Applied Biosystems, Inc., Foster
City, CA, USA) using the BigDie-Kit-Standard. Nucleotide
sequence data obtained were analyzed using MicroSeqID
v2.1.1 software (Applied Biosystems).
Microbial quantification by real-time qPCR
Specific primers targeting different bacterial genera were
used to characterize the fecal microbiota by quantitative
real-time qPCR (Table 1) [30-36]. Briefly, quantitative
PCR experiments were performed with a LightCycler 2.0
PCR sequence detection system using the FastStart DNA
Master SYBR Green kit (Roche Diagnostics, Indianapolis,
IN, USA). All PCR tests were carried out in duplicate,
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with a final volume of 20 μL containing 1 μL of each fecal
DNA preparation and 200 nM of each primer (Table 1).
The thermal cycling conditions used were as follows: an
initial DNA denaturation step at 95°C for 10 min; 45
cycles of denaturation at 95°C for 10 s; primer annealing
at optimal temperature for 20 s; extension at 72°C for 15 s.
Finally, melt curve analysis was performed by slowly cool-
ing the PCRs from 95°C to 60°C (0.05°C per cycle) with
simultaneous measurement of the SYBR Green I signal
intensity. Melting-point-determination analysis allowed
the confirmation of the specificity of the amplification pro-
ducts. Each participant’s extracted DNA was subjected to a
human b-globin PCR to ensure that amplifiable DNA was
successfully extracted from the sample and to monitor for
PCR inhibitors with the reaction conditions described pre-
viously [37]. The bacterial concentration from each sample
was calculated by comparing the threshold cycle values
obtained from the standard curves with the LightCycler
4.0 software. Standard curves were constructed for each
experiment using serial 10-fold dilutions of bacterial geno-
mic DNA (of known concentration) from pure cultures,
corresponding to 101 to 1010 copies per gram of feces.
The different strains used were obtained from the Span-
ish Collection of Type Cultures (CECT) (Bacteroides vul-
gatus NCTC 11154, Fusobacterium varium NCTC 10560,
Enterococcus faecalis CECT 184, Enterobacter cloacae
CECT 194, Clostridium perfringens CECT 376) and the
American Type Culture Collection (ATCC) (Bifidobacter-
ium bifidum ATCC 15696, Lactobacillus casei ATCC
334D-5, Prevotella intermedia ATCC 25611D-5, Rumino-
coccus productus ATCC 27340D-5 and Veillonella dispar
ATCC 17745). Standard curves were normalized to the
copy number of the 16S rRNA gene for each species. For
species for which the copy number of 16S rRNA operon
was not published, the copy number was calculated by
averaging the operon numbers of the closest bacterial taxa
from the ribosomal RNA database rrnDB [38]. Negative
controls containing all the elements of the reaction
mixture except template DNA were performed in every
analysis and no product was ever detected. The data pre-
sented are the mean values of duplicate real-time qPCR
analyses. The amplification efficiency of the qPCR for all
primer pairs was determined using the linear regression
slope of a dilution series based on the following equation
Table 1 Primers used for real-time PCR
Target group Oligonucleotide sequence (5′-3′) Reference Amplicon size (bp)
Bacteroidetes CATGTGGTTTAATTCGATGAT Guo et al. 2008 [30] 126
AGCTGACGACAACCATGCAG
Bacteroides GAGAGGAAGGTCCCCCAC Guo et al. 2008 [30] 106
CGCTACTTGGCTGGTTCAG
Lactobacillus GAGGCAGCAGTAGGGAATCTTC Delroisse et al. 2008 [31] 126
GGCCAGTTACTACCTCTATCCTTCTTC
Fusobacterium CCCTTCAGTGCCGCAGT Friswell et al. 2010 [32] 273
GTCGCAGGATGTCAAGAC
Firmicutes ATGTGGTTTAATTCGAAGCA Guo et al. 2008 [30] 126
AGCTGACGACAACCATGCAC
Actinobacteria CGCGGCCTATCAGCTTGTTG Stach et al. 2003 [33] 600
CCGTACTCCCCAGGCGGGG
Bifidobacterium CTCCTGGAAACGGGTGG Matsuki et al. 2004 [34] 550
GGTGTTCTTCCCGATATCTACA
Prevotella GGTTCTGAGAGGAAGGTCCCC Bekele et al. 2010 [35] 121
TCCTGCACGCTACTTGGCTG
Enterococcus CCCTTATTGTTAGTTGCCATCATT Rinttilä et al. 2004 [36] 144
ACTCGTTCTTCCCATGT
Proteobacteria CATGACGTTACCCGCAGAAGAAG Friswell et al. 2010 [32] 195
CTCTACGAGACTCAAGCTTGC
Clostridium Cluster IV GCACAAGCAGTGGAGT Matsuki et al. 2004 [34] 239
CTTCCTCCGTTTTGTCAA
Blautia coccoides-Eubacterium rectale group CGGTACCTGACTAAGAAGC Rinttilä et al. 2004 [36] 429
AGTTTCATTCTTGCGAACG
Veillonella ACCAACCTGCCCTTCAGA Rinttilä et al. 2004 [36] 343
CGTCCCGATTAACAGAGCTT
b-globin GAAGAGCCAAGGACAGGTAC Fredricks et al. 2007 [37] 270
CAACTTCATCCACGTTCACC
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E = 10(-1/slope). We found that for 13 primer pairs the effi-
ciency ranged from 98% (E = 1.96) to 100% (E = 2) with
slopes values in the range of -3.4 to -3.32.
Statistical analysis
Results are expressed as mean values and standard devia-
tions. The statistical analysis was performed with SPSS 15.0
software (SPSS Inc., Chicago, IL, USA). The sample size
was calculated to obtain a difference in the mean bacterial
number between the healthy children and those with type 1
diabetes of at least 2 × 105 copies per gram of feces. With a
power of 80%, an alpha error of 0.05 and an estimated stan-
dard deviation between group of 1.13 × 105 copies per
gram of feces (data obtained from Wu et al. [39]), six
children were needed in each group. However, we increased
the number of participants to 16 children and 16 controls.
The bacterial copy number values were converted into
logarithmic values before the statistical analysis. Given the
low number of participants analyzed, the Mann-Whitney U
test was used to check changes in bacterial number and
biochemical variables between the two groups. The Spear-
man correlation coefficient was calculated to estimate the
linear correlations between variables. A multivariate regres-
sion analysis was performed to identify individual bacteria
as independent predictors for plasma glucose level. Statisti-
cal significance was set at a P value of <0.05. All data are
presented in the text as the mean ± SD.
Results
Diet
The healthy children and those with diabetes all had simi-
lar physical activity and dietary habits. The analysis of the
food frequency questionnaires showed no significant
differences in the consumption patterns of rice, wheat,
vegetables, fish or meat between the two study groups,
although the children with diabetes had a fast carbohydrate
restriction (foods made with white flour and refined sugar).
Anthropometric and biochemical measurements
The anthropometric and biochemical variables of the
healthy children and those with diabetes are shown in
Table 2. Apart from the levels of glucose and HbA1c,
which were significantly higher in the children with dia-
betes, no other significant differences were seen between
the groups in the anthropometric and biochemical vari-
ables. In addition, because the healthy children and the
children with diabetes were matched for breastfeeding
time and mode of delivery, no significant differences
were noted in these variables.
PCR-DGGE and bacterial band identification
Variations were found in the presence or absence (quali-
tative) and intensity (quantitative) of the bands between
the healthy children and the children with diabetes in
the host-specific fingerprints generated. DGGE band
profiles showed differences in band richness between
the two groups. Analysis of the diversity of the micro-
biota showed that the mean of the DGGE bands was
13.85 ±3.87 for the healthy children and 11.63 ±3.64 for
the children with diabetes, though the difference was
not significant. Some bands were seen in fingerprints
from all the children (in different lanes but at the same
position), indicating that specific species of the predomi-
nant microbiota were common to all the children.
The Dice similarity coefficient was used to calculate
the similarity index between DGGE band profiles related
Table 2 Anthropometric and biochemical variables in healthy children and children with type 1 diabetes
Healthy children Children with type 1 diabetes P
N 16 16
Male/female 8/8 8/8
Vaginal delivery/Cesarean section 12/4 12/4
Age of debut (months) N/A 24.62 ±1.52
Diabetes duration (years) N/A 4.84 ±1.79
Age (years) 7.48 ±0.87 7.16 ±0.72 0.266
Body mass index (kg/m2) 16.35 ±0.82 16.57 ±0.95 0.489
Weight (kg) 25.15 ±2.12 24.88 ±1.98 0.712
Height (cm) 120.65 ±5.05 118.48 ±4.96 0.211
Birth weight 3.33 ±0.19 3.42 ±0.24 0.249
Glucose (mg/dL) 84.61 ±1.99 158.56 ±3.78 0.001
HbA1c (%) 4.47 ±0.21 7.63 ±0.43 0.001
Triglycerides (mg/dL) 56.54 ±6.43 56.93 ±4.92 0.849
Cholesterol (mg/dL) 162.84 ±11.46 164.89 ±9.76 0.590
Breast feeding time (months) 3.98 ±1.32 4.00 ±1.12 0.963
Values are presented as means ± SD. Relationships between both groups were analyzed using the Mann-Whitney U test. Values are significantly different for P
<0.05.
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to sampling of healthy children and those with diabetes.
The mean similarity index was 47.39% for the healthy
children and 37.56% for the children with diabetes. The
mean similarity index between the groups was 26.69%,
lower than the intra-group similarity (Table 3). The
DGGE gel and the results of the cluster analysis are
shown in Figure 1. The cluster analysis showed that the
intra-group similarity for the diabetic and the healthy
groups was significantly higher than the inter-group
similarity. These results demonstrate that the dominant
microbiota in the healthy group was different from that
of the diabetic group.
All the bands from the profiles of all the healthy children
and the children with diabetes were cloned and sequenced
to identify the dominant microbiota. The sequence simi-
larity matches for bands were analyzed by MicroSeqID
v2.1.1 software. Bacterial identification showed that the
majority of bacteria represented in the fingerprints
obtained corresponded to five phyla (Table 4). Most of the
sequences belonged to Firmicutes and Bacteroidetes, with
the rest distributed among Actinobacteria, Fusobacteria
and Proteobacteria. Nevertheless, we observed important
differences between the healthy children and the children
with diabetes in the distribution ratio of the different gen-
era within Bacteroidetes, Firmicutes and Actinobacteria
phyla. In the children with diabetes, we found an increase
in the Clostridium, Bacteroides, Veillonella, Eggerthella
and Bacillus frequencies and a disappearance of Prevotella
and Bifidobacterium as compared with the healthy
children (Table 4).
Comparative analysis of gut microbiota communities in
healthy children and children with diabetes
Changes in the bacterial population abundance were
assessed in the fecal samples of both groups. The results
obtained in the real-time qPCR experiments with the dif-
ferent primers are shown in Tables 5 and 6. Relevant dif-
ferences were found in the bacteria number of three
phyla between the diabetic and the healthy children. The
number of Actinobacteria, Firmicutes and Bacteroidetes
were significantly different between groups whilst the
quantity of Proteobacteria and Fusobacteria were similar
between the groups. In the children with diabetes, the
bacterial number of Actinobacteria and Firmicutes was
significantly decreased while that of Bacteroidetes was
significantly increased with respect to the healthy chil-
dren. Moreover, the Firmicutes to Bacteroidetes ratio was
significantly lower in the children with diabetes than the
healthy children.
Within Firmicutes, the quantity of Veillonella was signif-
icantly higher and the number of bacteria from the Blau-
tia coccoides-Eubacterium rectale group was significantly
lower in the children with diabetes compared with the
healthy children. The Lactobacillus number was signifi-
cantly lower and Clostridium levels significantly higher in
the children with diabetes. However, no significant differ-
ences were found in Enterococcus levels between the two
groups. Within Bacteroidetes, the quantity of Bacteroides
was significantly higher whereas the number of Prevotella
was significantly lower in the children with diabetes
compared with the healthy children. Finally, within
Actinobacteria, the number of Bifidobacterium was signifi-
cantly lower in the children with diabetes.
Relationship between gut microbiota composition in
children with type 1 diabetes and glycemic level
In the children with diabetes, we found a significant
univariate correlation between the amount of specific
bacterial groups and the plasma glucose levels (Bifidobac-
terium r = -0.797, P = 0.008; Clostridium r = 0.676, P <0.05;
Lactobacillus r = -0.698, P <0.05; and Firmicutes to Bacter-
oidetes ratio r = -0.473, P <0.05) and HbA1c levels (Bifido-
bacterium r = -0.573, P <0.05; Clostridium r = 0.452,
P <0.05; Firmicutes r = -0.559, P <0.05; Firmicutes to
Bacteroidetes ratio r = -0.765, P = 0.012). A multivariate
regression analysis that included all the bacterial groups
analyzed showed that only the reduction in the number of
Bifidobacterium and Lactobacillus was associated with the
plasma glucose level (P <0.05, b = -0.476, R2 = 0.587; and P
= 0.012, b = -0.687, R2 = 0.539, respectively) whereas the
higher HbA1c level was associated with the decrease in the
Firmicutes to Bacteroidetes ratio (P <0.001, b = -1.047, R2 =
0.781) and the increase in the number of Clostridium (P =
0.016, b = 0.867, R2 = 0.499).
Discussion
In the present study we found significant differences in the
fecal microbial composition between healthy children and
children with type 1 diabetes. We are unaware of any
other similar studies in children with type 1 diabetes using
simultaneously DGGE molecular profiling, unweighted
pair group method with arithmetic mean algorithm
Table 3 Microbiota diversity and similarity of healthy
and type 1 diabetes groups of children




Healthy 13.85 ±3.87 47.39 ±4.35 26.69 ±6.78
Diabetic 11.63 ±3.64 37.56 ±5.67
P 0.105 0.001 0.000
Values are presented as means ± SD. Data were analyzed using the Mann-
Whitney U test. Values are significantly different for P <0.05. aNumber of
DGGE bands produced by each sample analyzed. bDice similarity coefficients
comparing DGGE band profiles within individuals of the same group. cDice
similarity coefficients comparing DGGE band profiles between members of the
type 1 diabetes and the healthy groups.
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dendrogram construction, sequencing and real-time qPCR
analysis. To determine the characteristics of the gut micro-
biota based on the condition of just type 1 diabetes, we
excluded the influence of physiological factors such as age,
gender, dietary habits and race. In addition, we also con-
trolled for the mode of delivery at birth and the duration
of breastfeeding. This was because the first year of life has
a crucial impact on gut microbiota composition and
Figure 1 Cluster analysis. Dendrograms of electrophoretic band patterns obtained in the denaturing gel gradient electrophoresis experiment
with universal primers in the fecal samples collected from healthy children (H) and those with type 1 diabetes (D). (A) Cluster analysis; (B) DGGE
profiles related to fecal samples; (C) line graph.
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epidemiological studies in humans at genetic risk for type
1 diabetes have suggested that a short duration of breast-
feeding and early feeding in infancy with complex dietary
proteins such as cow’s milk proteins can modulate the
development of beta cell autoimmunity, clinical type 1
diabetes, or both [40-42]. No significant differences were
found between the two groups of children (type 1 diabetes
and controls).
The DGGE analysis of the fecal microbiota revealed a
significantly lower intra-group similarity index in chil-
dren with diabetes than in healthy children. In other
words, the DGGE profiles in healthy children were more
similar to each other, whereas in children with diabetes
they were less similar. A similar result was found by
Giongo et al. [21]. These data suggest that diabetic
status may influence specific bacterial groups of the gut
microbiota community.
Sequence analysis of the DGGE bands cloned enable
the association of specific bacterial genotypes with
health or diabetes situations. Consistent with previous
human and animal studies [11,21,39,37,43], the gut
microbiota of healthy children and children with dia-
betes was predominately composed of Firmicutes and
Bacteroidetes and the main difference lies in the propor-
tion of genus-division bacteria within this two phyla and
the Actinobacteria phylum between both the group with
diabetes and the healthy group. These results suggest
that the dominant microbiota genera are different in
children with type 1 diabetes compared with healthy
children. Recently, three robust clusters, referred to as
“enterotypes”, which are not nation or continent specific
have been identified. Assignment of an individual micro-
biome into a given enterotype is based upon the relative
enrichment of that microbiome in one of three genera:
Table 4 Bacterial identification after sequencing the bands cloned from the DGGE analysis of fecal samples in the







Veillonella 4 (7.7%) 9 (18%) 99.97
Bacillus 0 2 (4%)) 99.82
Clostridium 6 (11.5%) 15 (30%) 99.95
Gemella 4 (10%) 2 (4%) 99.86
Phylum Fusobacteria
Leptotrichia 4 (7.7%) 3 (6%) 99.94
Phylum Actinobacteria
Bifidobacterium 6 (11.5%) 0 99.75
Eggerthella 0 4 (8%) 99.90
Phylum Proteobacteria
Desulfovibrio 4 (7.7%) 3(6%) 99.75
Phylum Bacteroidetes
Prevotella 16 (30.7%) 0 99.68
Bacteroides 5 (9.6%) 10 (20%) 99.89
Pedobacter 3 (5.8%) 2 (4%) 99.47
aRefers to the frequency (and percent) of each unique bacteria genus in the type 1 diabetic group and healthy group. n refers to the number of bands cloned,
sequenced and identified in each study group. N = 16 participants per group.
Table 5 Real-time PCR quantification of microbiota phyla in healthy children and children with type 1 diabetes
Healthy children Children with type 1 diabetes P
Proteobacteria 7.74 ±0.64 7.97 ±1.12 0.481
Actinobacteria 6.32 ±0.45 5.47 ±0.93 0.003
Fusobacteria 6.61 ±1.19 6.99 ±1.28 0.391
Firmicutes 9.85 ±0.43 6.54 ±0.56 0.001
Bacteroidetes 9.98 ±0.74 10.92 ±0.83 0.002
Firmicutes to Bacteroidetes ratio 0.97 ±0.19 0.62 ±0.24 0.001
Values are presented as means ±SD and expressed as log10 copies per gram of feces. N = 16 participants per group. Relationships between both groups were
analyzed using the Mann-Whitney U test. Values are significantly different for P <0.05.
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Bacteroides (enterotype 1), Prevotella (enterotype 2) or
Ruminococcus (enterotype 3) [44]. In this study, within
Bacteroidetes, the Bacteroides genus was prevalent in
the diabetic group, whereas the Prevotella genus was
associated with the healthy group. Thus, the type 1
diabetic gut microbiomes could be classified into entero-
type 1 and the healthy microbiomes could be classified
into enterotype 2.
As DGGE is considered a semiquantitative tool for mon-
itoring the dynamics of the predominant bacterial species
of fecal microbiota, an additional analysis with real-time
qPCR was performed to obtain a quantitative estimation
of the changes found in the gut microbiota between
children with diabetes and healthy children. We noted sig-
nificant quantitative differences between the major micro-
bial phyla present in the feces of healthy children and
those with diabetes. In contrast to the situation in healthy
children, we found a significant increase in the quantity of
Bacteroidetes and a significant decrease in the number of
Firmicutes and Actinobacteria in children with type 1
diabetes. Our data showed a significantly lower Firmicutes
to Bacteroidetes ratio in children with type 1 diabetes
compared with healthy children. Moreover, we saw a
negative correlation between this ratio and both the glu-
cose and the HbA1C levels in children with diabetes,
which could help to explain the significantly higher
glycemic level in this group. In agreement with this,
Giongo et al. observed that the Firmicutes to Bacteroidetes
ratio in study participants with type 1 diabetes was
changing during the first 6 months after birth before the
development of the autoimmune disease. These authors
showed a successive decline in Firmicutes and an increase
in Bacteroidetes number in the gut microbiome over time
until the children became diabetic [21]. Moreover, this
imbalance observed at the phylum level between Bacteroi-
detes and Firmicutes has been previously described in
several human disorders. A decline in the Firmicutes to
Bacteroidetes ratio compared with controls has been
described in human type 2 diabetes [45], whereas in
Crohn´s disease, both Bacteroidetes and Firmicutes seem
to decline [46]. The opposite happens in obesity, where
the imbalance is due to the increase in the Firmicutes to
Bacteroidetes ratio [47], indicating that obesity and dia-
betes are associated with different groups of intestinal
microbiota.
However, the major difference between the two groups
was found in the number of bacteria at genus-division
level. The most remarkable result was the significant
increase in the number of Clostridium, Bacteroides and
Veillonella in the children with diabetes, whereas the
number of Lactobacillus, Bifidobacterium, the Blautia coc-
coides/Eubacterium rectale group and Prevotella genus
were all significantly decreased in children with diabetes.
Our findings concerning the microbiota of children with
diabetes are in line with observations in other animal
studies. Roesch et al. found higher levels of Lactobacillus
and Bifidobacterium in BioBreeding diabetes-resistant rats
whereas Bacteroides and Clostridium were more abundant
in BioBreeding diabetes-prone rats [27]. In contrast with
this, however, Brown et al. found that Lactobacillus and
Bifidobacterium were more abundant in participants with
type 1 diabetes than in healthy participants [22].
The significant decrease in the number of Lactobacil-
lus and Bifidobacterium observed in children with type
1 diabetes in our study was associated with their higher
levels of plasma glucose, as indicated by the negative
correlation found. Also, the regression analysis showed
that the decrease in the number of Lactobacillus and
Bifidobacterium could be associated with the plasma
glucose level in the children with diabetes. In previous
studies, the levels of Bifidobacterium have also been
related to improved glucose metabolism, insulin resis-
tance and low-grade inflammation [48,49]. Moreover,
Valladares et al. determined that the administration of
Lactobacillus johnsonii isolated from BioBreeding dia-
betes-resistant rats delays or inhibits the onset of type 1
diabetes in BioBreeding diabetes-prone rats [10].
Both Lactobacillus and Bifidobacterium have members
with probiotic characteristics and these have been
associated with positive effects for the host in the large
intestine [50]. In addition, both bacterial groups have the
capacity to produce the beneficial organic acid lactate,
which is converted into butyrate by butyrate-producing
bacteria in the gut [22]. Barcenilla et al. [51] showed that
most of the butyrate-producing isolates from human fecal
samples are related to the Blautia coccoides-Eubacterium
rectale group. Previous studies have shown that butyrate
induces mucin synthesis (a glycoprotein produced by the
host that could maintain the integrity of the gut epi-
thelium) [52], decreases bacterial transport across the
Table 6 Genera and groups within the phyla Firmicutes,
Bacteroidetes and Actinobacteria in healthy children and
children with type 1 diabetes
Healthy
children
Children with type 1
diabetes
P
Prevotella 10.95 ±0.57 9.03 ±0.99 0.001
Clostridium 4.85 ±0.34 6.87 ±0.52 0.001
B. Coccoides-E
rectale
8.64 ±0.72 6.99 ±0.47 0.001
Enterococcus 5.80 ±1.35 5.94 ±1.21 0.760
Veillonella 6.76 ±0.82 8.93 ±1.12 0.001
Bifidobacterium 5.65 ±1.14 3.12 ±0.97 0.001
Lactobacillus 4.23 ±0.36 3.47 ±0.43 0.001
Bacteroides 8.64 ±0.45 10.67 ±0.63 0.001
Values are presented as means ±SD and expressed as log10 copies per gram
of feces. N = 16 participants per group. Relationships between both groups
were analyzed using the Mann-Whitney U test. Values are significantly
different for P <0.05.
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epithelium [53], and improves gut integrity by increasing
tight junction assembly [54]. In addition, the genera Prevo-
tella are responsible for the degradation of this mucin
[55]; thus, the significant decline in the numbers of the
Blautia coccoides-Eubacterium rectale group and Prevo-
tella that we found in children with type 1 diabetes com-
pared with healthy children could indicate a reduction in
mucin synthesis by the host and a lack of this mucin on
the epithelial layer of the gut, which would lead to a signif-
icant alteration in intestinal permeability. Other studies
have described an association between type 1 diabetes and
compromised barrier permeability in humans and both
the NOD mouse and BioBreeding rat models [16-18,20].
The significant increase in the number of Clostridium,
Bacteroides and Veillonella in the children with diabetes
with respect to the healthy children was accompanied by a
significant positive correlation between both the plasma
levels of glucose and HbA1c and the quantity of Clostri-
dium. These bacteria are able to ferment glucose and lac-
tate to propionate, acetate and succinate. However, these
short fatty acids do not induce mucin synthesis [52]. This
situation would, though, reduce the tight junction assem-
bly, generating an increase in the gut permeability in chil-
dren with type 1 diabetes [22].
Finally, we propose a possible mechanism to explain
the relationship we have found between the gut micro-
biota present in children with type 1 diabetes and the
glycemic levels observed. The short-chain fatty acids
(such as butyrate and propionate) formed by this gut
microbiota have a role in the regulation of the levels of
gut hormones such as glucose-dependent insulinotropic
polypeptide, glucagon-like peptide 1 and ghrelin. These
hormones have important effects on carbohydrate meta-
bolism [56], thus allowing gut microbiota to affect glyce-
mic levels. In addition, Huml et al. have previously
demonstrated an altered secretion pattern of gut
hormones in children with type 1 diabetes that may
impact on the metabolic control of diabetes in these
patients [57]. Further studies will be necessary to demon-
strate this proposed mechanism.
A limitation of the 16S rRNA gene-based method is
that the function of the identified bacteria is unknown.
Future studies using a microbial metagenomic sequen-
cing analysis will be carried out to obtain information
about the functional diversity of the bacterial commu-
nity analyzed here.
Conclusions
This is the first study showing that type 1 diabetes is
associated with compositional changes in gut micro-
biota. Our results show that gut microbiota found in
children with type 1 diabetes differed significantly from
that found in healthy children. The gut microbiota in
the children with diabetes was less similar than the gut
microbiota in the healthy children. The significant
differences between the diabetic and the healthy chil-
dren in the number of Bifidobacterium, Lactobacillus
and Clostridium and the Firmicutes to Bacteroidetes
ratio could be implicated in the glycemic level of the
children with diabetes. In addition, the numbers of lactic
acid-producing bacteria, butyrate-producing bacteria and
mucin-degrading bacteria, essential to maintain gut
integrity, were significantly lower in the children with
diabetes than the healthy children. These bacterial dif-
ferences could be responsible for the altered gut perme-
ability previously described in patients with type 1
diabetes. These findings could be useful for developing
strategies to control the development of type 1 diabetes
by modifying the gut microbiota.
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